32.76BMarket Cap12.38P/E (TTM)
12.300High11.820Low2.14MVolume11.820Open12.000Pre Close26.01MTurnover0.39%Turnover Ratio12.38P/E (Static)2.67BShares22.74052wk High0.65P/B6.77BFloat Cap11.32052wk Low0.46Dividend TTM551.94MShs Float80.880Historical High0.460Dividend LFY4.00%Amplitude6.197Historical Low12.135Avg Price500Lot Size3.75%Div YieldTTM3.75%Div Yield LFY
FOSUN PHARMA Stock Forum
HSI Slides 342 Pts; Techs & Pharmas Gloom
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-SW(09988.HK)$ dived 3.2% to $84.1.
$TENCENT(00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W(03690.HK)$ , $XIAOMI-W(01810.HK)$ , ...
ColumnsExpert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
$Pfizer(PFE.US)$$AIM VACCINE(06660.HK)$
In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...
Bloomberg: Chinese mRNA Shot Beat Sinovac as Booster But Caused More Fevers
$Sinovac Biotech(SVA.US)$ $FOSUN PHARMA(02196.HK)$ $Shanghai Fosun Pharmaceutical(600196.SH)$ $CanSino Biologics Inc.(688185.SH)$ $CANSINOBIO(06185.HK)$ $Walvax Biotechnology(300142.SZ)$ $Chongqing Zhifei Biological Products(300122.SZ)$
$FOSUN PHARMA(02196.HK)$ Fosun Pharma (02196.HK) yesterday disclosed the third quarterly report data, Q3 company revenue was 10.095 billion yuan, a year-on-year increase of 25.03%; net profit was 1.082 billion yuan, a year-on-year increase of 41.62%.
The growth of Fosun Pharma’s performance is due to alleviation of the pressure of centralized procurement and price reduction of stock varieties. According to the announcement, as of October 24, Fosun Pharma’s Fubitai (mRNA Covid-19 vaccine) has been vaccinated in Hong Kong, Macau and Taiwan over 9.7 million. Agent.
Article excerpted from the U.S. Stock Intelligence Agency
We added fosun Pharmaceutical today.
Because I want to be a butterfly
No comment yet